Actively Recruiting
Circulating Tumor Cells (CTC) in Cancer
Led by University Hospital, Basel, Switzerland · Updated on 2025-03-12
3000
Participants Needed
2
Research Sites
513 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study with circulating tumor cells (CTC) count, isolation and analysis at several time points during disease progression is to investigate the role and biology of CTCs and clusters of CTCs in different cancer types. It also evaluates the role of CTCs as biomarkers, and aims at the identification of key signaling networks that are active in CTCs.
CONDITIONS
Official Title
Circulating Tumor Cells (CTC) in Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult cancer patients
- Histology-based confirmed cancer diagnosis of any stage or subtype (precancerous lesions excluded)
- Diagnosis of a solid tumor including adenocarcinoma, squamous cell carcinoma, neuroendocrine carcinoma, or sarcoma
- Written pathology report available
- Written informed consent provided
You will not qualify if you...
- No written informed consent
- No confirmed diagnosis of malignancy by pathology report
- Diagnosis of blood cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University Hospital Basel
Basel, Switzerland, 4031
Actively Recruiting
2
Department Oncology, Haematology & Immuntherapy, Kantonsspital Baselland
Liestal, Switzerland, 4410
Actively Recruiting
Research Team
M
Marcus Vetter, PD Dr. med.
CONTACT
N
Nicola Aceto, Prof. Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here